1. Home
  2. QRHC vs NERV Comparison

QRHC vs NERV Comparison

Compare QRHC & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quest Resource Holding Corporation

QRHC

Quest Resource Holding Corporation

HOLD

Current Price

$1.93

Market Cap

32.3M

Sector

Utilities

ML Signal

HOLD

Logo Minerva Neurosciences Inc

NERV

Minerva Neurosciences Inc

HOLD

Current Price

$3.97

Market Cap

29.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QRHC
NERV
Founded
N/A
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Environmental Services
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.3M
29.2M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
QRHC
NERV
Price
$1.93
$3.97
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
84.1K
40.4K
Earning Date
11-10-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$261,281,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.10
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.11
$1.15
52 Week High
$6.75
$12.46

Technical Indicators

Market Signals
Indicator
QRHC
NERV
Relative Strength Index (RSI) 52.34 51.62
Support Level $1.90 $3.70
Resistance Level $2.30 $4.07
Average True Range (ATR) 0.17 0.29
MACD -0.04 0.00
Stochastic Oscillator 38.47 62.37

Price Performance

Historical Comparison
QRHC
NERV

About QRHC Quest Resource Holding Corporation

Quest Resource Holding Corp is a national provider of waste and recycling services to customers from across multiple industry sectors that are typically larger, multi-location businesses. The company creates customer-specific programs and perform the related services for the collection, processing, recycling, disposal, and tracking of waste streams and recyclables. The company's services focus on the waste streams and recyclables from box, grocers, and other specialty retailers; automotive after-market operations such as automotive maintenance, quick lube, dealerships, and collision repair; transportation, logistics, and fleet operators; manufacturing and industrial facilities; multi-family and commercial properties; restaurant chains and food operations, etc.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.

Share on Social Networks: